tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew L Kaplan, 1734 are a BUY (83.33%), 347 are a HOLD (16.67%).
Analyst Matthew L Kaplan works at LADENBURG with a stock forecast success ratio of 50.83% fulfilled within 509.6 days on average.
Matthew L Kaplan’s has documented 63 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 25-Feb-2022.
Analyst best performing recommendations are on TGTX (TG THERAPEUTICS).
The best stock recommendation documented was for TGTX (TG THERAPEUTICS) at 5/12/2020. The price target of $44 was fulfilled within 217 days with a profit of $24.06 (120.66%) receiving and performance score of 5.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
14
$7.49 (115.05%)
13
7 days ago
5/10 (50%)
$7.45 (113.74%)
251
Buy
15
$8.49 (130.41%)
2 months 1 days ago
4/14 (28.57%)
$6.32 (72.81%)
441
Buy
14
$7.49 (115.05%)
9
3 months 14 days ago
3/7 (42.86%)
$4.92 (54.19%)
231
Buy
15
$8.49 (130.41%)
12
3 months 15 days ago
0/2 (0%)
$5.9 (64.84%)
Buy
11
$4.49 (68.97%)
9
5 months 23 days ago
2/3 (66.67%)
$7.06 (179.19%)
122
What Year was the first public recommendation made by Matthew L Kaplan?
